ATE242002T1 - Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose - Google Patents

Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose

Info

Publication number
ATE242002T1
ATE242002T1 AT00900306T AT00900306T ATE242002T1 AT E242002 T1 ATE242002 T1 AT E242002T1 AT 00900306 T AT00900306 T AT 00900306T AT 00900306 T AT00900306 T AT 00900306T AT E242002 T1 ATE242002 T1 AT E242002T1
Authority
AT
Austria
Prior art keywords
necrosis factor
tumor necrosis
use against
factor antagonists
against endometriosis
Prior art date
Application number
AT00900306T
Other languages
English (en)
Inventor
Francesco Borrelli
Antonio Mauro D
Fabrizio Martelli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE242002(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE242002T1 publication Critical patent/ATE242002T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00900306T 1999-01-22 2000-01-19 Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose ATE242002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101194A EP1022027A1 (de) 1999-01-22 1999-01-22 Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose
PCT/IB2000/000052 WO2000043031A1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis

Publications (1)

Publication Number Publication Date
ATE242002T1 true ATE242002T1 (de) 2003-06-15

Family

ID=8237393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900306T ATE242002T1 (de) 1999-01-22 2000-01-19 Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose

Country Status (30)

Country Link
US (2) US6663865B1 (de)
EP (2) EP1022027A1 (de)
JP (1) JP4601176B2 (de)
KR (2) KR20060128056A (de)
CN (2) CN1212152C (de)
AR (1) AR022251A1 (de)
AT (1) ATE242002T1 (de)
AU (1) AU771964B2 (de)
BG (1) BG65556B1 (de)
BR (1) BR0008182A (de)
CA (1) CA2356737C (de)
CZ (1) CZ302866B6 (de)
DE (1) DE60003152T2 (de)
DK (1) DK1143997T3 (de)
EA (1) EA003927B1 (de)
EE (1) EE05543B1 (de)
ES (1) ES2200808T3 (de)
HK (1) HK1043059B (de)
HU (1) HU226149B1 (de)
IL (2) IL144413A0 (de)
NO (1) NO328814B1 (de)
NZ (1) NZ512585A (de)
PL (1) PL204713B1 (de)
PT (1) PT1143997E (de)
SI (1) SI1143997T1 (de)
SK (1) SK287313B6 (de)
TR (1) TR200102107T2 (de)
UA (1) UA78483C2 (de)
WO (1) WO2000043031A1 (de)
ZA (1) ZA200105263B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326562C (zh) * 2001-01-29 2007-07-18 应用研究系统Ars股份公司 Il－18抑制剂制造治疗和/或预防心脏病的药物的应用
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1709965A3 (de) 2001-07-11 2006-12-27 Boehringer Ingelheim Pharmaceuticals, Inc. Methode zur Behandlung von zytokinvermittelten Erkrankungen
US7082134B1 (en) * 2002-01-18 2006-07-25 Juniper Networks, Inc. Redirect checking in a network device
US20070298041A1 (en) * 2002-06-28 2007-12-27 Tomlinson Ian M Ligands That Enhance Endogenous Compounds
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
AU2003212569A1 (en) * 2003-02-07 2004-08-30 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis
WO2005023761A2 (en) 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
GB0327112D0 (en) 2003-11-21 2003-12-24 Clincial Designs Ltd Dispenser and reservoir
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
EP1765083A4 (de) * 2004-05-28 2008-08-20 Serono Lab Verwendung von il-17 bei der behandlung von fruchtbarkeitsstörungen
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
JP5544458B2 (ja) * 2005-07-12 2014-07-09 アンピオ ファーマシューティカルズ，インコーポレイテッド 疾病を治療するための医薬製品の製造においてトリロスタンｉｉｉを使用する方法及びトリロスタンｉｉｉを含む医薬製品
JP2010528647A (ja) * 2007-06-06 2010-08-26 ドマンティス リミテッド ポリペプチド、抗体可変ドメインおよびアンタゴニスト
SG177302A1 (en) * 2009-06-22 2012-02-28 Dmi Acquisition Corp Methods and products for treatment of diseases
JP5833549B2 (ja) 2009-06-22 2015-12-16 アンピオ ファーマシューティカルズ，インコーポレイテッド 血管透過性亢進を抑制するためのダナゾールを含む製薬組成物
CN104968350A (zh) 2012-12-19 2015-10-07 安皮奥制药股份有限公司 疾病的治疗方法
EP3265493B1 (de) 2015-03-02 2024-01-10 180 Therapeutics LP Verfahren zur behandlung einer lokalisierten fibrotischen erkrankung unter verwendung eines il-33-antagonisten

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037805A (en) * 1989-03-20 1991-08-06 The Salk Institute For Biological Studies Methods of contraception
EP1857553A1 (de) * 1991-03-18 2007-11-21 New York University Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
AU670125B2 (en) * 1992-09-15 1996-07-04 Immunex Corporation Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
US5389657A (en) * 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
US5747532A (en) * 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
GB9607120D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
GB9616643D0 (en) * 1996-08-08 1996-09-25 Chiroscience Ltd Compounds
WO1998023284A1 (en) * 1996-11-27 1998-06-04 Immunex Corporation Method of regulating nitric oxide production
US6514977B1 (en) * 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
TR200102107T2 (tr) 2001-12-21
ZA200105263B (en) 2002-06-26
HUP0105103A3 (en) 2004-08-30
US20040057954A1 (en) 2004-03-25
SK10292001A3 (sk) 2001-12-03
US6663865B1 (en) 2003-12-16
WO2000043031A1 (en) 2000-07-27
CZ20012656A3 (cs) 2002-02-13
KR100685106B1 (ko) 2007-02-22
EP1143997A1 (de) 2001-10-17
IL144413A (en) 2009-05-04
KR20060128056A (ko) 2006-12-13
KR20010101397A (ko) 2001-11-14
BG105691A (en) 2002-02-28
CA2356737A1 (en) 2000-07-27
AU1997300A (en) 2000-08-07
HU226149B1 (en) 2008-05-28
EP1143997B1 (de) 2003-06-04
EP1022027A1 (de) 2000-07-26
NO20013577D0 (no) 2001-07-19
BR0008182A (pt) 2001-11-06
CN1698894A (zh) 2005-11-23
DE60003152T2 (de) 2004-03-25
NZ512585A (en) 2003-08-29
JP2002535284A (ja) 2002-10-22
UA78483C2 (en) 2007-04-10
CZ302866B6 (cs) 2011-12-21
EA003927B1 (ru) 2003-10-30
SK287313B6 (sk) 2010-06-07
CN100594932C (zh) 2010-03-24
PT1143997E (pt) 2003-10-31
ES2200808T3 (es) 2004-03-16
SI1143997T1 (en) 2003-12-31
IL144413A0 (en) 2002-05-23
HK1043059A1 (en) 2002-09-06
DE60003152D1 (de) 2003-07-10
CA2356737C (en) 2010-03-23
EE05543B1 (et) 2012-06-15
PL204713B1 (pl) 2010-02-26
JP4601176B2 (ja) 2010-12-22
HK1082690A1 (zh) 2006-06-16
DK1143997T3 (da) 2003-09-15
PL350002A1 (en) 2002-10-21
EA200100799A1 (ru) 2001-12-24
CN1337883A (zh) 2002-02-27
EE200100378A (et) 2002-10-15
BG65556B1 (bg) 2008-12-30
AR022251A1 (es) 2002-09-04
NO20013577L (no) 2001-08-29
NO328814B1 (no) 2010-05-18
HK1043059B (zh) 2005-11-18
CN1212152C (zh) 2005-07-27
AU771964B2 (en) 2004-04-08
HUP0105103A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
DE60003152D1 (de) Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose
DE60027479D1 (de) Harzstruktur und ihre verwendung
DE60106423D1 (de) Entzündungshemmende verbindungen und ihre verwendung
DE60016326D1 (de) Wasser-absorbierende Zusammensetzung und ihre Verwendung
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
AU2003301662A8 (en) Quinazolinones and derivatives thereof as factor xa inhibitors
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
DE69926800D1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
ATE376357T1 (de) Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide
ATE370958T1 (de) Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ATE315554T1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
DE60017894D1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
DE60112791D1 (de) Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität
ATE332294T1 (de) Dihydro-1,3,5-triazin-diamin-derivate und ihre therapeutische verwendung
DE60027927D1 (de) Harzstruktur und ihre verwendung
DE60106607D1 (de) Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
ATE419366T1 (de) Tyra-gene und ihre verwendung
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
ATE384054T1 (de) Substituierte benzoxazinones und ihre verwendung
ATE419248T1 (de) Phenylsubstituierte 4-hydroxy-tetrahydropyridone und ihre verwendung als schädlingsbekämpungsmittel und herbizide
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
DE60030366D1 (de) Flexible Harzzusammensetzung und ihre Verwendung
DE50008427D1 (de) Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143997

Country of ref document: EP

EEFA Change of the company name